vTv Therapeutics Inc.

US$21.03As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VTVTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (20.73%)
Div yield —
ROE (10.95%)
Biotechnology
Beta (5Y) 0.26
PE TTM —
TSR TTM (3.31%)
Mkt cap US$261.3M
ROIC (9.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$22
5.34%
(39.94%)
Hold 12|10|2|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.30
0.29
0.32
0.35
34.48%
18.89%
20.74%
21.94%
Revenue$M
32.33
32.06
32.33
32.71
8.13%
8.05%
5.24%
3.54%
Peers (US$261.3M)
Cap (US$)
PE
259.2M
—
Capital
TTM
5Y
10Y
Leveragex
2.599
0.272
0.231
EBIT/Intx
2.779
0.053
0.055
Own earn%
(11.86)
62.56
55.87
Sh yield%
26.95
38.34
38.27
Owners
Insiders/Inst%
0.86
29.24
Short interest%
0.56
SBC / revenue%
2.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
10–18
$1 testx
—
Incr. ROIC%
6